Annual SG&A
$10.83 M
+$1.35 M+14.26%
31 December 2023
Summary:
Sunshine Biopharma annual selling, general & administrative expenses is currently $10.83 million, with the most recent change of +$1.35 million (+14.26%) on 31 December 2023. During the last 3 years, it has risen by +$10.22 million (+1685.19%). SBFMW annual SG&A is now at all-time high.SBFMW Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.73 M
+$733.42 K+24.52%
30 September 2024
Summary:
Sunshine Biopharma quarterly selling, general & administrative expenses is currently $3.73 million, with the most recent change of +$733.42 thousand (+24.52%) on 30 September 2024. Over the past year, it has increased by +$1.28 million (+52.55%). SBFMW quarterly SG&A is now -41.91% below its all-time high of $6.41 million, reached on 31 December 2022.SBFMW Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$261.66 M
-$4.23 M-1.64%
30 September 2024
Summary:
Sunshine Biopharma TTM selling, general & administrative expenses is currently -$261.66 million, with the most recent change of -$4.23 million (-1.64%) on 30 September 2024. Over the past year, it has dropped by -$276.08 million (-1914.32%). SBFMW TTM SG&A is now -1194151.20% below its all-time high of $14.42 million, reached on 30 September 2023.SBFMW TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.3% | +52.5% | -1914.3% |
| 3 y3 years | +1685.2% | +1135.6% | -10000.0% |
| 5 y5 years | - | - | - |
SBFMW Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1685.2% | -41.9% | +1681.7% | -139.6% | at low |
| 5 y | 5 years | at high | +1685.2% | -41.9% | +1681.7% | -299.6% | at low |
| alltime | all time | at high | +1685.2% | -41.9% | +1681.7% | <-9999.0% | at low |
Sunshine Biopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.73 M(+24.5%) | $12.90 M(+11.0%) |
| June 2024 | - | $2.99 M(-11.1%) | $11.62 M(+5.0%) |
| Mar 2024 | - | $3.36 M(+19.3%) | $11.07 M(+2.2%) |
| Dec 2023 | $10.83 M(+14.3%) | $2.82 M(+15.5%) | $10.83 M(-24.9%) |
| Sept 2023 | - | $2.44 M(-0.0%) | $14.42 M(+7.6%) |
| June 2023 | - | $2.44 M(-21.9%) | $13.40 M(+14.7%) |
| Mar 2023 | - | $3.13 M(-51.3%) | $11.68 M(+23.3%) |
| Dec 2022 | $9.48 M | $6.41 M(+351.0%) | $9.48 M(+189.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $1.42 M(+96.6%) | $3.28 M(+52.0%) |
| June 2022 | - | $723.19 K(-21.5%) | $2.16 M(+29.8%) |
| Mar 2022 | - | $921.40 K(+340.7%) | $1.66 M(-11.0%) |
| Dec 2021 | $1.87 M(+207.6%) | $209.08 K(-30.6%) | $1.87 M(-4.5%) |
| Sept 2021 | - | $301.48 K(+32.2%) | $1.95 M(+18.3%) |
| June 2021 | - | $228.00 K(-79.8%) | $1.65 M(+16.0%) |
| Mar 2021 | - | $1.13 M(+280.3%) | $1.42 M(+380.3%) |
| Dec 2020 | $606.64 K(-2.6%) | $296.38 K | $296.38 K |
| Dec 2019 | $622.73 K | - | - |
FAQ
- What is Sunshine Biopharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Sunshine Biopharma?
- What is Sunshine Biopharma annual SG&A year-on-year change?
- What is Sunshine Biopharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly SG&A year-on-year change?
- What is Sunshine Biopharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Sunshine Biopharma?
- What is Sunshine Biopharma TTM SG&A year-on-year change?
What is Sunshine Biopharma annual selling, general & administrative expenses?
The current annual SG&A of SBFMW is $10.83 M
What is the all time high annual SG&A for Sunshine Biopharma?
Sunshine Biopharma all-time high annual selling, general & administrative expenses is $10.83 M
What is Sunshine Biopharma annual SG&A year-on-year change?
Over the past year, SBFMW annual selling, general & administrative expenses has changed by +$1.35 M (+14.26%)
What is Sunshine Biopharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of SBFMW is $3.73 M
What is the all time high quarterly SG&A for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly selling, general & administrative expenses is $6.41 M
What is Sunshine Biopharma quarterly SG&A year-on-year change?
Over the past year, SBFMW quarterly selling, general & administrative expenses has changed by +$1.28 M (+52.55%)
What is Sunshine Biopharma TTM selling, general & administrative expenses?
The current TTM SG&A of SBFMW is -$261.66 M
What is the all time high TTM SG&A for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM selling, general & administrative expenses is $14.42 M
What is Sunshine Biopharma TTM SG&A year-on-year change?
Over the past year, SBFMW TTM selling, general & administrative expenses has changed by -$276.08 M (-1914.32%)